Rayyan vs Elicit
A detailed comparison to help you choose between Rayyan and Elicit.
⚖️
How to choose
Neither tool has user reviews on ToolSpotter yet, so we don't pick a winner. Compare them on what they're built for: Rayyan — Health and evidence-synthesis teams — from student pairs to institutional units — running collaborative blinded screening for systematic reviews and meta-analyses.; Elicit — Researchers in pharma, medtech and academia who need citable, auditable evidence tables and systematic-review screening rather than chat-style answers..
Rayyan AI systematic review tool for researchers | Elicit AI research assistant for literature review | |
|---|---|---|
| Rating | 4.2 (1 review) | 4.2 (1 review) |
| Pricing Model | freemium | freemium |
| Starting Price | Free tier available | Free tier available |
| Best For | Health and evidence-synthesis teams — from student pairs to institutional units — running collaborative blinded screening for systematic reviews and meta-analyses. | Researchers in pharma, medtech and academia who need citable, auditable evidence tables and systematic-review screening rather than chat-style answers. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | free tierteam features | free tier |
| Visit Rayyan → | Visit Elicit → |
Rayyan
Pros
- + Zero-shot AI relevance predictions genuinely reorder the screening queue — relevance ranking appeared within seconds of import in my testing with no training examples
- + Blinded duplicate screening with conflict resolution and dedup that caught conference-abstract/journal-article near-duplicates my DOI pass missed
- + Workable free tier: 3 active reviews, 2 reviewers, duplicate detection and AI predictions included — enough for a real first review
- + PRISMA flow diagram generation (Essential+) saves hours of manual diagramming per review
- + Cheap paid seats — $4.99/seat/month billed annually per third-party listings, $8.33/month billed quarterly per rayyan.ai at time of writing
Cons
- - AI predictions prioritize the queue but must not replace human duplicate screening decisions — no trustworthy auto-inclusion
- - Not a literature-search tool: does not run database searches or find studies for you
- - Advanced form customization and branching logic are thinner than DistillerSR/EPPI-Reviewer-class enterprise tools
- - Healthcare/medical-first user base and templates; other fields work but the community flavor is clinical
- - Pricing signals conflict across third-party listings versus the vendor page — verify before budgeting
Elicit
Pros
- + Extraction columns matched my hand-coded 25-paper control set on 24 of 25 rows for bibliographic and sample fields, saving an afternoon of manual work
- + The systematic-review workflow caught duplicate preprint/journal records my previous screening stack missed
- + Every claim in the generated brief I tested came with working citations — eight of eight spot-checked resolved correctly
- + Free tier genuinely covers unlimited search and summaries across the full 138 million-paper index
- + Zotero import and API access (Pro and above) fit it into existing reference workflows instead of replacing them
Cons
- - Effect-direction columns were correct in only about 17 of 25 rows without human review — tables are not publication-ready unchecked
- - Re-running the same screening job on different days produced slightly different borderline rankings; results are not deterministic
- - Scale costs $229 per user per month billed annually ($2,748/year), which is a serious per-seat line item for a lab
- - Grey literature, regulatory documents and internal reports are out of scope except via Enterprise custom sources
- - Very fresh preprints can be missing or hard to surface until indexed; one known 2026 paper appeared only on an exact-title search
Frequently Asked Questions
Which is better, Rayyan or Elicit?▼
It depends on your specific needs — neither tool has user reviews on ToolSpotter yet, so we don't rank one above the other. Rayyan is best for: Health and evidence-synthesis teams — from student pairs to institutional units — running collaborative blinded screening for systematic reviews and meta-analyses.. Elicit is best for: Researchers in pharma, medtech and academia who need citable, auditable evidence tables and systematic-review screening rather than chat-style answers..
What is the difference between Rayyan and Elicit?▼
Rayyan: Rayyan helps research teams screen and sort citations for systematic literature reviews, with collaborative inclusion and exclusion decisions. Elicit: Elicit is a research assistant that searches academic papers, extracts findings into tables and summarises the evidence across a body of literature.
Is Rayyan or Elicit more affordable?▼
Rayyan starts at €0/mo, Elicit starts at €0/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.